Click here for more
Click here for more
Click here for more
 
Artificial Insemination
You are here: Urology>Procedures>Artificial Insemination


Anatomy
Diseases
Procedures/Investigation
  Cystocopy
  Sperm Washing
  Urethral Catheterization
  Artificial Insemination
Photo Gallery

ARTIFICIAL INSEMINATION

Artificial insemination (AI) is the introduction of sperm into a woman’s reproductive tract by any means other than through sexual intercourse. It is one of the treatment modalities utilized in the management of infertility where preconditions permit.

The procedure can be performed using either a sexual partner’s sperm (husband insemination) or a donor’s sperm (donor insemination).

The donor may or may not be known to the female recipient. The donors are tested for infectious diseases including HIV, HBV and screened for certain genetic diseases.

The sperm is usually placed in the cervix (intracervical insemination) or in the uterus (intrauterine insemination). In intrauterine insemination, sperm is injected directly into a woman’s uterus thus allowing the sperm to bypass the cervix enabling more sperm to successfully reach the uterine cavity and fallopian tubes where fertilization usually takes place. Both procedures are best performed at the time of ovulation, which may be determined by basal body temperature, ovulation test chart, cervical mucus examination, hormonal profile and ultrasound scan.For women with irregular ovulation patterns, medication may be used to induce ovulation prior to artificial insemination. Timing of the insemination procedure with ovulation is essential.

The male’s sperm is analyzed via seminal fluid analysis to determine if it is suitable for insemination.

For academic purpose it is important to note that other modes of AI note also utilized include intrafallopian insemination and intraperitoneal insemination, procedures in which sperm is introduced near the mouth of the fallopian tubes and ovaries. However these are not as popular as intracervical or intrauterine.

In most cases, abnormalities with the male factor is the indication for AI with less indications from the female via cervical factors that prevent the sperm from entering the uterus from the vagina. It is not recommended for women whose infertility can be linked to tubal factors, uterine abnormalities, active pelvic infection or anovulation.

AI is thus indicated if the couple’s problems are related to conditions that make it difficult for the man’s sperm to reach the woman’s uterus.

Artificial insemination may be recommended thus increasing the chances of fertilization when either partner is diagnosed with:

Male Factors

-Unexplained infertility

-Erectile dysfunction -drugs, alcohol.

-Premature ejaculation

-Sperm abnormalities: Oligospermia-Low sperm count

Asthenospermia (decreased ability to move)

Abnormal sperm morphology (abnormal shape and structure)

Sperm antibodies (antibodies produced by the body to destroy the sperm)

Retrograde ejaculation (a condition that causes semen to be released backward into the bladder at male climax)

-Hypospadias (a congenital condition in which the urethra opens on the underside of the penis)

Female Factors

-Unexplained infertility

-Poor interaction between sperm and cervical mucus

-Cervix disorders

-Endometriosis

AI may involve a donor which maybe may be a known or unknown individual. A donor may be recommended for a number of reasons, such as:

-Severe semen abnormality.

-Male partner has a sexually transmissible disease e.g. HIV, HBV

-One or both partners carry a heritable disorder. A couple may choose donor insemination when there is potential for hereditary disease in their offspring.

Artificial Insemination: Preconditions
Before a woman undergoes artificial insemination, the cause of the infertility must be diagnosed. The woman must also have the regularity of her ovulation asserted.

The male partner’s sperm must be analyzed to determine if it is suitable for insemination. The required sperm can be collected in a number of ways including:

· Cup collection. This method requires a man to masturbate and ejaculate into a sterile cup.

· Condom collection. During this process, semen is collected during intercourse using a special condom.

· Split ejaculate. This method uses a two–part container to collect sperm. The initial spurt should be collected in one part of the container, and the rest is collected in the second part.

· Urine collection. During this process, semen is collected from urine sample of the male partner in a laboratory. This is an option for men who have retrograde ejaculation.

The sample must be collected no more than two hours before the scheduled insemination time.

In some cases, men having treatments that cause or may cause sterility, including testicular surgery, vasectomy, prostate surgery, radiation and/or chemotherapy for cancer treatment, may choose to store their sperm for future use in an artificial insemination. Single women may require donated sperm. In either case, sperm, which can be frozen indefinitely, is stored in containers of liquid nitrogen until it is required.

Sperm being used for an intrauterine insemination (IUI) must first be washed. This procedure removes substances that may cause complications. It also concentrates the semen into a small sample of the most active sperm, thus increasing the chance of fertilization.

Artificial Insemination: procedure
Artificial insemination is performed when a woman is ovulating. Ovulation occurs when a follicle from the ovary releases a mature egg. If a woman's cycle is regular, it usually occurs 14 days before the start of their next menstrual period. Ovulation is often estimated with the aid of basal body temperature charts, ovulation test kits and a cervical mucus examination. Blood tests measuring levels of the hormone LH (luteinizing hormone) and ultrasound pelvic scans may also be used. The procedure is performed 30-34 hours after the spontaneous LH surge or 40-44 hours after the administration of medication. Prophylactic antibiotics are not necessary unless a medical indication exists (eg, history of mitral valve prolapse). For women undergoing ovulation induction, the chances are greatly increased and timing the insemination procedure with ovulation is essential.

The procedure is quite simple taking only a few minutes to perform. It is performed on an out-patient basis and may be done once or twice a month, depending on the regularity of the woman’s menstrual cycle.

With the patient lying supine, the legs are hung on a stir-up, the vulva clean and a speculum is inserted into the vagina. This is a plastic or metal instrument that helps to hold open the vagina and expose the cervix. A catheter, a thin plastic tube is inserted into the vagina until it reaches the cervix. A special syringe filled with washed donor sperm is attached to the end of the catheter. The sperm sample is pushed out of the syringe and travels through the catheter, where it is deposited around the cervix. In intrauterine insemination, the sperm is deposited in the uterus. It has a higher success rate. A soft sponge cap may be placed over the cervix in order to prevent leakage of any sperm. This sponge can be removed between six and eight hours after the procedure. You will be asked to rest for a short time after the procedure has been performed – usually 30 minutes.

Artificial Insemination: After the procedure
Following the procedure, the woman should be able to resume normal activities. Ovulation may be monitored via ultrasound for the next three days to confirm its occurrence.

Chances of success are higher where the woman is less than 35yrs of age, has been pregnant before and insemination is done on the expected day of ovulation. Use of drugs to induce ovulation also increases the chances as well.

Success when achieved occurs usually within the first six cycles of therapy, however if the reverse is the case, other forms of treatment, such as In Vitro Fertilization (IVF) Intracytoplasmic Sperm Injection (ICSI) and Gamete Intrafallopian Transfer (GIFT), may be employed.

Success Rates
Intracervical insemination success rates are about comparable to those associated with intravaginal insemination. Typical success rates range from about 5% to 30% per cycle, depending upon the quality of the sperm sample used and the female's reproductive health status. Insemination is typically performed twice each cycle, to increase the chances of pregnancy.

Sperm washing can help to boost your the of success with intracervical insemination. Sperm washing is a preparation method used to weed out slower and less healthy sperm cells.

Summary
Artificial insemination, it is a quite simple procedure with few side effects. The success rates for artificial insemination are not colossal being in the area of 15 percent, each cycle. However, it is less expensive and invasive than other forms of Assisted Reproductive Technology (ART). Artificial insemination also allows for fertilization to occur naturally in the body.

The demerits of the procedure are few and include the uncommon introduction of infection into the female reproductive tract and for those the that require induction, the ever popular risk of multiple pregnancy and its attendant risk.

For IUI, IVF, and ICSI procedures, the removal of certain components of the ejaculate (ie, seminal fluid, excess cellular debris, leukocytes, morphologically abnormal sperm) with the retention of the motile fraction of sperm is desirable.

After sperm preparation, the spermatozoa are enhanced in motility and become activated and ready to fertilize an oocyte. Currently, no reliable technique allows the separation of the X- and Y-bearing spermatozoa. IUI is performed during a natural cycle or after ovulation induction with medication.

The average pregnancy rate achieved after a natural-cycle IUI is 8%. The rate increases to 10-12% after clomiphene citrate ovulation induction and to 12-15% per cycle after hMG/hCG ovulation induction. Of the successful pregnancies, 85% are achieved within the first 4 cycles of IUIs.

Homologous insemination refers to the use of sperm from the patient's partner. Heterologous or therapeutic insemination (TI), refers to the use of frozen sperm that has been quarantined for at least 6 months. Thereafter, the specimen is ready to use once the donor has undergone the necessary screening tests The source of the sperm can be either anonymous or from a designated donor previously accepted by the infertile couple. A cumulative pregnancy rate of 80% is achieved during the first 6 cycles of TI.



 
Terms and Conditions | Privacy Policy | Disclaimer
Copyright © 2007 St. Mary's Specialist Centre